387 related articles for article (PubMed ID: 28306568)
1. Ketamine for cancer pain: what is the evidence?
Jonkman K; van de Donk T; Dahan A
Curr Opin Support Palliat Care; 2017 Jun; 11(2):88-92. PubMed ID: 28306568
[TBL] [Abstract][Full Text] [Related]
2. Low dose ketamine use in the emergency department, a new direction in pain management.
Pourmand A; Mazer-Amirshahi M; Royall C; Alhawas R; Shesser R
Am J Emerg Med; 2017 Jun; 35(6):918-921. PubMed ID: 28285863
[TBL] [Abstract][Full Text] [Related]
3. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of Opioid-Refractory Cancer Pain with Short-Course, Low-Dose Ketamine.
Waldfogel JM; Nesbit S; Cohen SP; Dy SM
J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):294-297. PubMed ID: 27754734
[TBL] [Abstract][Full Text] [Related]
5. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
Amin P; Roeland E; Atayee R
J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
[TBL] [Abstract][Full Text] [Related]
6. The use of ketamine as adjuvant therapy to control severe pain.
Campbell-Fleming JM; Williams A
Clin J Oncol Nurs; 2008 Feb; 12(1):102-7. PubMed ID: 18258579
[TBL] [Abstract][Full Text] [Related]
7. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
Grande LA; O'Donnell BR; Fitzgibbon DR; Terman GW
Anesth Analg; 2008 Oct; 107(4):1380-3. PubMed ID: 18806055
[TBL] [Abstract][Full Text] [Related]
8. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.
Elsewaisy O; Slon B; Monagle J
Pain Med; 2010 Jun; 11(6):946-50. PubMed ID: 20624244
[TBL] [Abstract][Full Text] [Related]
9. [Parenteral administration of low dose ketamine for the treatment of neuropathic pain in cancer patients].
Kong PE; Snijdelaar DG; Crul BJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2556-8. PubMed ID: 12532671
[TBL] [Abstract][Full Text] [Related]
10. Oral ketamine for neuropathic cancer pain.
Calsina-Berna A; Alvaro Pardo M; Cucurull Salamero M; Bleda-Perez M; Julià-Torras J
BMJ Support Palliat Care; 2024 Jan; 13(e3):e968-e970. PubMed ID: 37225396
[TBL] [Abstract][Full Text] [Related]
11. Intranasal Ketamine and Its Potential Role in Cancer-Related Pain.
Singh V; Gillespie TW; Harvey RD
Pharmacotherapy; 2018 Mar; 38(3):390-401. PubMed ID: 29396996
[TBL] [Abstract][Full Text] [Related]
12. Ketamine for analgesia.
Daley M; Roberts JC; Washington S
Br J Hosp Med (Lond); 2012 Jun; 73(6):358. PubMed ID: 22875332
[No Abstract] [Full Text] [Related]
13. Analgesic effects of topical ketamine.
Kopsky DJ; Keppel Hesselink JM; Bhaskar A; Hariton G; Romanenko V; Casale R
Minerva Anestesiol; 2015 Apr; 81(4):440-9. PubMed ID: 24847738
[TBL] [Abstract][Full Text] [Related]
14. Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer: a pilot study.
Courade M; Bertrand A; Guerrini-Rousseau L; Pagnier A; Levy D; Lervat C; Cojean N; Ribrault A; Dugue S; Thouvenin S; Piguet C; Schmitt C; Marec-Berard P
BMJ Support Palliat Care; 2022 Nov; 12(e5):e656-e663. PubMed ID: 31151954
[TBL] [Abstract][Full Text] [Related]
15. A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia.
McCartney CJ; Sinha A; Katz J
Anesth Analg; 2004 May; 98(5):1385-400, table of contents. PubMed ID: 15105220
[TBL] [Abstract][Full Text] [Related]
16. Ketamine in pain management.
Cohen SP; Liao W; Gupta A; Plunkett A
Adv Psychosom Med; 2011; 30():139-161. PubMed ID: 21508630
[TBL] [Abstract][Full Text] [Related]
17. The Use of Ketamine as an Adjunct to Treating Opioid Refractory Cancer-Related Pain in the Emergency Department.
Brockett-Walker C
Adv Emerg Nurs J; 2019; 41(2):101-106. PubMed ID: 31033656
[TBL] [Abstract][Full Text] [Related]
18. Subanalgesic ketamine enhances morphine-induced antinociceptive activity without cortical dysfunction in rats.
Shikanai H; Hiraide S; Kamiyama H; Kiya T; Oda K; Goto Y; Yanagawa Y; Shimamura K; Goda Y; Togashi H
J Anesth; 2014 Jun; 28(3):390-8. PubMed ID: 24113864
[TBL] [Abstract][Full Text] [Related]
19. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients.
Kannan TR; Saxena A; Bhatnagar S; Barry A
J Pain Symptom Manage; 2002 Jan; 23(1):60-5. PubMed ID: 11779670
[TBL] [Abstract][Full Text] [Related]
20. A review of the use of ketamine in pain management.
Tawfic QA
J Opioid Manag; 2013; 9(5):379-88. PubMed ID: 24353050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
